Eli Lilly’s weight loss drug semaglutide, sold under brand names such as Ozempic and Wegovy, has transformed how clinicians and patients approach obesity and type 2 diabetes. This GLP-1 receptor agonist enhances insulin release, slows gastric emptying, and reduces appetite, leading to significant reductions in body weight and blood sugar.
Originally developed for diabetes, semaglutide is now widely prescribed for chronic weight management in adults with obesity or overweight conditions accompanied by weight-related health issues. Understanding how it works, how it differs from other treatments, and what to expect can help people use it safely and effectively.
| Aspect | Semaglutide (Wegovy) | Tirzepatide (Mounjaro) | Typical Titration Timeline |
|---|---|---|---|
| Drug Class | GLP-1 agonist | Dual GLP-1 and GIP agonist | Weeks 1–4: Starting dose |
| Primary Use for Weight | Chronic weight management | Type 2 diabetes and weight | Weeks 5–8: Titration to target |
| Typical Weight Loss | 12–18% of body weight in trials | Up to 20–25% in some studies | Weeks 9+: Maintenance evaluation |
| Common Dosing Frequency | Once weekly | Once weekly | Adjust based on tolerance and goals |
| Key Monitoring Parameters | Weight, A1C, blood pressure | Weight, A1C, gastrointestinal symptoms | Regular follow-up with clinician |
How Semaglutide Works in the Body
Semaglutide mimics the hormone GLP-1, which the gut releases after eating. By activating GLP-1 receptors in the brain, it increases feelings of fullness and reduces hunger. In the digestive system, it slows stomach emptying, which helps prevent sharp blood sugar spikes after meals.
For people with type 2 diabetes, this improved blood sugar control can reduce long-term complications. For people using it for weight loss, the appetite effects often lead to a natural decrease in calorie intake without strict dieting. Understanding these mechanisms helps patients set realistic expectations about rate and sustainability of weight loss.
Eligibility and Prescription Considerations
Health care providers typically prescribe semaglutide for adults with a body mass index of 30 or higher, or 27 and above when weight-related conditions such as high blood pressure or prediabetes are present. A thorough medical history and current medication review are essential, as semaglutide can interact with other drugs and may not be suitable for everyone.
Because it is a controlled substance in many regions due to its potential for misuse, semaglutide requires a prescription and ongoing monitoring. Patients should discuss kidney function, digestive conditions, and mental health history with their provider before starting therapy.
Dosing, Administration, and Practical Tips
Semaglutide is delivered through a pre-filled weekly injection, usually in the abdomen, thigh, or upper arm. Dosing starts low and increases gradually to minimize nausea, vomiting, and diarrhea, which are common when beginning therapy. Following the titration schedule recommended by the clinician can improve tolerance over time.
Taking the medication on an empty stomach, staying well hydrated, and eating bland foods during the adjustment period can reduce gastrointestinal side effects. Patients should store it according to label instructions and report persistent or severe symptoms rather than adjusting the dose on their own.
Potential Side Effects and Safety Concerns
Gastrointestinal symptoms such as nausea, constipation, and abdominal pain are the most frequently reported side effects, especially during dose escalation. In rare cases, semaglutide has been associated with gallbladder problems, kidney issues, and changes in heart rate, so ongoing monitoring is important.
People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should avoid this medication. Anyone experiencing severe abdominal pain, difficulty swallowing, or signs of an allergic reaction should seek medical care immediately.
Lifestyle Strategies to Support Treatment
While semaglutide can significantly reduce appetite, combining it with consistent lifestyle changes often produces the best results. Behavioral strategies such as mindful eating, regular physical activity, and structured meal planning help people maintain weight loss after discontinuing higher doses.
Working with a dietitian or diabetes educator can provide practical tools for managing cravings, reading food labels, and building sustainable routines. These supports are especially valuable when adjusting to new appetite regulation and when considering long-term weight maintenance.
Key Takeaways for People Considering Semaglutide
- Semaglutide is a once-weekly GLP-1 agonist effective for significant weight loss and diabetes control.
- Eligibility depends on body mass index, medical history, and treatment goals under professional supervision.
- Starting low and titrating slowly helps manage gastrointestinal side effects.
- Ongoing monitoring, healthy eating, and regular movement improve long-term outcomes.
- Discuss risks, benefits, and lifestyle expectations with a qualified health care provider.
FAQ
Reader questions
Will semaglutide cause muscle loss during weight loss?
It can lead to some loss of lean mass if protein intake is too low and resistance training is not performed, but combining adequate protein, strength exercises, and regular activity helps preserve muscle while losing fat.
Can I stop semaglutide and keep the weight off?
Many people regain weight after stopping, because the medication suppresses appetite and alters metabolism; long-term success often depends on sustained lifestyle changes and, in some cases, ongoing medical support.
How does this compare to older weight loss medications?
Compared with older drugs, semaglutide produces larger weight losses and better improvements in blood sugar and cardiovascular risk factors, but it may cause more nausea and requires regular follow-up for dose optimization.
Is it covered by insurance for weight loss, or is it only for diabetes?
Coverage varies by plan and region; many insurers cover it for type 2 diabetes, and some provide coverage for weight management when specific criteria are met, so patients should check with their plan and provider.